SEC Form 3 · accession 0002149586-26-000002

Minerva Neurosciences, Inc. · NERV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Accounting Officer

Period of report

Aug 10, 2026

Accepted (ET)

Aug 20, 2026 · 4:38 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001598646

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	holding	—	—		—	1,683	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F1	$27.68	holding	—	—	—	—	Sep 15, 2030	Common Stock	5,000	—	D
Employee Stock Option (right to buy)^F1	$6.33	holding	—	—	—	—	Feb 15, 2032	Common Stock	8,750	—	D
Employee Stock Option (right to buy)^F2	$3.11	holding	—	—	—	—	Dec 12, 2032	Common Stock	19,167	—	D
Employee Stock Option (right to buy)^F3	$6.41	holding	—	—	—	—	Oct 3, 2033	Common Stock	20,000	—	D
Employee Stock Option (right to buy)^F4	$2.12	holding	—	—	—	—	Dec 4, 2034	Common Stock	22,000	—	D
Employee Stock Option (right to buy)^F5	$3.98	holding	—	—	—	—	Dec 21, 2035	Common Stock	300,000	—	D
Employee Stock Option (right to buy)^F6	$4.84	holding	—	—	—	—	May 31, 2036	Common Stock	150,000	—	D

F1Fully vested.
F2The option vested 25% on December 13, 2023 and then vests or vested in equal quarterly installments over 3 years thereafter.
F3The option vested 25% on October 4, 2024 and then vests or vested in equal quarterly installments over 3 years thereafter.
F4The option vested 25% on December 5, 2025 and then vests or vested in equal quarterly installments over 3 years thereafter.
F5The option vests 25% on December 22, 2026 and then in equal quarterly installments over 3 years thereafter.
F6The option vests 25% on June 1, 2027 and then in equal quarterly installments over 3 years thereafter.